Medscape | Entecavir May Prevent HBV Reactivation in Lymphoma Patients Medscape Antiviral prophylaxis with entecavir might help prevent rituximab-associated hepatitis B virus (HBV) reactivation in patients with lymphoma and resolved hepatitis B, according to a randomized controlled trial. Yi-Hsiang Huang, MD, PhD, from Taipei ... |
